EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC 4.0

Hyperlipidemia Management in Primary Care: A Practical Review of Risk Stratification, Guideline Directed Therapy and Emerging Lipid Lowering Treatment

Paulamy Ganguly iD, Brittany Jackson, Carlos Vergara Sanchez iD, Sergey Turchin, Dana M Harris iD

Journal of Primary Care & Community Health · 2026-10 · 17

DOI: 10.1177/21501319261505033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Primary Care & Community Health, online erschienen am 02.11.2026. Verfasst von Paulamy Ganguly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA. Hauptthemen laut MEDLINE: Hypolipidemic Agents, Hyperlipidemias, Primary Health Care. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperlipidemia is a leading modifiable contributor to atherosclerotic cardiovascular disease (ASCVD) and the leading cause of mortality worldwide. Early identification and evidence-based management of dyslipidemia are essential components of cardiovascular risk reduction in primary care. Recent updates in lipid management guidelines including the 2026 American College of Cardiology and American Heart Association have expanded risk assessment tools, emphasized earlier measurement of lipoprotein (a), apolipoprotein B (apo-B) and coronary artery calcium (CAC), and incorporated novel lipid lowering therapy (LLT). This review provides a practical framework for primary care physicians to evaluate and manage dyslipidemia through a stepwise approach that integrates lifestyle interventions, statins, non-statin therapies and emerging agents. We summarize current evidence regarding lipid physiology, risk stratification, diagnostic strategies and guideline directed pharmacologic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypolipidemic AgentsHyperlipidemiasPrimary Health CareHumansRisk AssessmentPractice Guidelines as TopicHydroxymethylglutaryl-CoA Reductase Inhibitors

Stichwörter der Autor:innen

ASCVDDyslipidemiaEzetimibeHyperlipidemiaInclisiranLDLLDL-CPCSK9 inhibitorsStatinshypertriglyceridemialipoprotein (a)primary carerisk stratification

Substanzen

Hypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Division of Community Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.

ORCID-Profile: Paulamy Ganguly, Carlos Vergara Sanchez, Dana M Harris

Zitieren

APA

Ganguly, P., Jackson, B., Vergara Sanchez, C., Turchin, S., & Harris, D. M. (2026). Hyperlipidemia Management in Primary Care: A Practical Review of Risk Stratification, Guideline Directed Therapy and Emerging Lipid Lowering Treatment. Journal of Primary Care & Community Health, 17. https://doi.org/10.1177/21501319261505033

Vancouver

Ganguly P, Jackson B, Vergara Sanchez C, Turchin S, Harris DM. Hyperlipidemia Management in Primary Care: A Practical Review of Risk Stratification, Guideline Directed Therapy and Emerging Lipid Lowering Treatment. Journal of Primary Care & Community Health. 2026;17. doi:10.1177/21501319261505033

BibTeX
@article{Ganguly2026,
  author = {Ganguly, Paulamy and Jackson, Brittany and Vergara Sanchez, Carlos and Turchin, Sergey and Harris, Dana M},
  title = {Hyperlipidemia Management in Primary Care: A Practical Review of Risk Stratification, Guideline Directed Therapy and Emerging Lipid Lowering Treatment},
  journal = {Journal of Primary Care & Community Health},
  year = {2026},
  volume = {17},
  doi = {10.1177/21501319261505033}
}
Kostenlos starten →